Post-approval studies (Phase 4)Ended earlyNCT06162663
What this trial is testing
Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer Survivors
Who this might be right for
Breast CancerInsomnia
Medical University of South Carolina 6